(IMMU) |
| 0 (0%) 10-06 23:08 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 10.03 |
| Resistance 1: | 9.53 |
| Pivot price: | 9.09 |
| Support 1: | 8.71 |
| Support 2: | 7.25 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.950 |
| Book Value | 10.980 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.711 |
| Profit Margin (%) | 134.48 |
| Operating Margin (%) | 78.28 |
| Return on Assets (ttm) | 2.1 |
| Return on Equity (ttm) | 8.8 |
Company news
Thu, 01 Oct 2026
Mendus AB (publ) (IMMU) Posts 5-Year AML Follow-Up, CML Trial Progress - TradingView
Mon, 24 Aug 2026
Mendus (Q2 Review): Important CML Readout Near - TradingView
Sat, 18 Jul 2026
We Think Mendus (STO:IMMU) Needs To Drive Business Growth Carefully - Simply Wall Street
Tue, 27 Jan 2026
T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases - Nature
Tue, 11 Nov 2025
Fuzon comes back after six years with new vocalist - The Express Tribune
Fri, 23 Feb 2024
A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer - Frontiers
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
